Protalix BioTherapeutics Announces Closing of Private Note Exchange Aug 26, 2021 06:50AM
Protalix BioTherapeutics Announces Private Note Exchange Aug 13, 2021 06:50AM
Protalix BioTherapeutics Announces $43.7 Million in Financing to Further Advance its Programs in Fabry Disease Mar 12, 2020 07:55AM